:

Being a Part of the Impact!

Project Impact: A Campaign to Defeat Pediatric Brain Tumors provides multiple ways to get involved and invest in this revolutionary program. Please consider donating today!

Recognition Opportunities

Special naming and commemoration opportunities will be integral to the Project Impact Campaign, acting as critical tools in the successful solicitation of leadership and major gifts by providing incentives to donors to invest, while also providing high-level and public recognition opportunities in exchange for those investments.

Examples of potential investment opportunities include:

  • Endowments to name cores and positions within the program
  • Sponsor research grants
  • Sponsor research cores
  • Sponsor matching gifts
  • Sponsor genome sequencing efforts or clinical trials>/li>

Community and Personal Donation Commitments

Community Events: Host a community event to raise money for pediatric research.

Host information sessions: Attend or host an informational session to raise awareness of the need for pediatric brain tumor research.

Get Involved: Volunteer to advocate for policies that promote pediatric cancer and brain tumor research.

Personal and legacy giving: Invest in the campaign though a personal commitment, or consider legacy giving as part of your last will and testament.

Employer matching: Find out if your employer has a matching gift program and direct that funding to pediatric research.

Learn More
For more information, contact Wendi Nance Huff or 617 658 7035

“It’s an exciting time in increasing our understanding of this disease. We need to keep the momentum up – from finding mutations, to understanding how they work and how they impact clinical decisions. This is an exciting time to advance this project.”

– Dr. Suzanne Baker, PhD St. Jude Children’s Research Hospital

“We haven’t moved the needle in decades, and that is unacceptable for kids and families. When my patients get the diagnosis, I meet with the family for the first time, and we’re already talking about end of life. That is unacceptable. We need the courage to move to precision medicine and take risks to save these kids.”

– Dr. Sabine Mueller, MD University of California, San Francisco